TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

Tatsuya Ioka, Makoto Ueno, Hideki Ueno, Joon Oh Park, Heung Moon Chang, Naoki Sasahira, Masashi Kanai, Ik Joo Chung, Masafumi Ikeda, Shoji Nakamori, Nobumasa Mizuno, Yasushi Omuro, Taketo Yamaguchi, Hiroki Hara, Kazuya Sugimori, Junji Furuse, Hiroyuki Maguchi, Masayuki Furukawa, Kengo Fukuzawa, Jun Suk KimSeigo Yukisawa, Masahiro Takeuchi, Takuji Okusaka, Narikazu Boku, Ichinosuke Hyodo

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)'. Together they form a unique fingerprint.

    Medicine & Life Sciences